ET01 - Treatment After Metformin: What Are Your Options?

Explore the roles of native GLP-1 in T2D pathophysiology. Review the recommendations from national association guidelines on the treatment options after metformin in the T2D treatment algorithm. Evaluate the efficacy and safety results from a monotherapy trial of a once-daily GLP-1 RA as well as 2 other head-to-head clinical trials, including vs an SGLT-2i and a DPP-4i. Evaluate the safety data from a cardiovascular outcomes trial, followed by dosing and administration information.